<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04928391</url>
  </required_header>
  <id_info>
    <org_study_id>17300616</org_study_id>
    <nct_id>NCT04928391</nct_id>
  </id_info>
  <brief_title>A Single Bolus of Dexmedetomidine Versus Nalbuphine in Postoperative Agitation</brief_title>
  <official_title>Optic Nerve Sheath Diameter (ONSD): A New Modality to Assess Postoperative Agitation After a Single Bolus of Dexmedetomidine Versus Nalbuphine in Children With Cleft Palate Repair</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The hypothesis of this study is to investigate and compare the efficacy between the&#xD;
      administrations of single intravenous (IV) dose of dexmedetomidine versus nalbuphine in&#xD;
      preventing immediate postoperative agitation in children undergoing cleft palate repair.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A written informed consent will be taken from the guardian of children.Patients will be&#xD;
      assigned randomly to three groups (30 subjects each) to be anesthetized. The study drug will&#xD;
      be delivered in opaque bags labeled &quot;study drug&quot; and 90 patients will be allocated in three&#xD;
      groups (of 30 patients each) to receive the study drug at the end of surgery; a single dose&#xD;
      of 0.5 µ/kg IV dexmedetomidine (Group D) or a single dose of 0.1 mg/kg IV nalbuphine (Group&#xD;
      N) or same volume of saline placebo (Group C).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 20, 2021</start_date>
  <completion_date type="Anticipated">December 10, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 5, 2021</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>the Pediatric Anesthesia Emergence Delirium (PAED) score</measure>
    <time_frame>1 hour postoperative</time_frame>
    <description>Emergence delirium (ED) will be measured by the Pediatric Anesthesia Emergence Delirium (PAED) scale. The scores for each of the five listed behaviours (The child makes eye contact with the caregiver/parent, the child's actions are Purposeful, the child is aware of his/her surroundings, the child is restless and the child is inconsolable) are added to achieve a total score (maximum score of 20). A score of ≥ 12 yields 100% sensitivity and 94.5% specificity for the diagnosis of ED</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>FLACC (Face, Legs, Activity, Cry, and Consolability) pain score.</measure>
    <time_frame>1 hour postoperative</time_frame>
    <description>The FLACC is a behavioural pain assessment scale for use for non-verbal or pre-verbal patients unable to self-report their level of pain. Rate your child in each of the five measurement categories, add together, and document total pain score (0 - 10), score 0= relaxed and no pain, 1-3= mild pain/discomfort, 4-6= moderate pain, 7-10= severe discomfort/pain.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Cleft Palate</condition>
  <arm_group>
    <arm_group_label>Group D</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Dexmedetomidine IV at the end of surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group N</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Nalbuphine IV at the end of surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group C</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Same volume of saline placebo IV at the end of surgery</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexmedetomidine</intervention_name>
    <description>A single dose of 0.5 µ/kg IV dexmedetomidine at the end of surgery</description>
    <arm_group_label>Group D</arm_group_label>
    <other_name>Precedex</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Nalbuphine</intervention_name>
    <description>A single dose of 0.1 mg/kg IV nalbuphine at the end of surgery</description>
    <arm_group_label>Group N</arm_group_label>
    <other_name>nalufin</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>0.9% saline</intervention_name>
    <description>Same volume of saline placebo IV at the end of surgery</description>
    <arm_group_label>Group C</arm_group_label>
    <other_name>Normal saline</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Children (age 1-7 years) of American Society of Anaesthesiologists physical status&#xD;
             (ASA) I-II&#xD;
&#xD;
          -  Elective cleft palate repair ± cleft lip surgery under general anesthesia.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Ventriculo-peritoneal shunt&#xD;
&#xD;
          -  Suspected meningitis&#xD;
&#xD;
          -  Congenital hydrocephalus&#xD;
&#xD;
          -  Clinical signs of suspected increased intracranial pressure&#xD;
&#xD;
          -  On treatment for seizures or metabolic diseases&#xD;
&#xD;
          -  Children with developmental delay&#xD;
&#xD;
          -  Hypersensitivity to dexmedetomidine or nalbuphine&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Year</minimum_age>
    <maximum_age>7 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Omar Soliman</last_name>
    <role>Study Director</role>
    <affiliation>Assiut University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Omar Soliman, MD</last_name>
    <phone>01101266040</phone>
    <email>omarmakram347@yahoo.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Omar Soliman</name>
      <address>
        <city>Assiut</city>
        <state>Assuit</state>
        <zip>Assuit universi</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Omar Soliman</last_name>
      <phone>01101266040</phone>
      <email>omarmakram347@yahoo.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Assiut university hospital</name>
      <address>
        <city>Assiut</city>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <results_reference>
    <citation>Milić M, Goranović T, Knezević P. Complications of sevoflurane-fentanyl versus midazolam-fentanyl anesthesia in pediatric cleft lip and palate surgery: a randomized comparison study. Int J Oral Maxillofac Surg. 2010 Jan;39(1):5-9. doi: 10.1016/j.ijom.2009.09.007. Epub 2009 Oct 24.</citation>
    <PMID>19854614</PMID>
  </results_reference>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>June 10, 2021</study_first_submitted>
  <study_first_submitted_qc>June 10, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 16, 2021</study_first_posted>
  <last_update_submitted>August 24, 2021</last_update_submitted>
  <last_update_submitted_qc>August 24, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 26, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Omar Makram Soliman</investigator_full_name>
    <investigator_title>Lecturer of anesthesia and ICU</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cleft Palate</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexmedetomidine</mesh_term>
    <mesh_term>Nalbuphine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

